Annual Meeting of the Society for Biological TherapyJournal of immunotherapy (1997). 1999, Vol 22, Num 5, pp 454-471, issn 1524-9557Conference Proceedings

Annual Meeting of the Society for Biological TherapyJournal of immunotherapy with emphasis on tumor immunology. 1997, Vol 20, Num 5, pp 399-421, issn 1067-5582Conference Proceedings

Annual Meeting of the Society for Biological TherapyJournal of immunotherapy with emphasis on tumor immunology. 1996, Vol 19, Num 6, pp 456-468, issn 1067-5582Conference Proceedings

International Scientific Meeting of the Society for Biological TherapyJournal of immunotherapy (1997). 2000, Vol 23, Num 5, pp 581-596, issn 1524-9557Conference Proceedings

Society for Biological Therapy. Annual meetingJournal of immunotherapy. 1993, Vol 14, Num 4, pp 357-369, issn 1053-8550Conference Proceedings

Annual Scientific Meeting of the Society for Biological TherapyJournal of immunotherapy (1997). 2002, Vol 25, Num 6, pp S1-S41, issn 1524-9557Conference Proceedings

Society for Biological Therapy. Annual meetingJournal of immunotherapy. 1994, Vol 16, Num 3, pp 234-249, issn 1053-8550Conference Proceedings

Annual Scientific Meeting of the Society for Biological TherapyJournal of immunotherapy (1997). 2001, Vol 24, Num 5, pp S1-S26, issn 1524-9557Conference Proceedings

Society for Biological Therapy. Annual meetingJournal of immunotherapy with emphasis on tumor immunology. 1995, Vol 18, Num 2, pp 127-137, issn 1067-5582Conference Proceedings

Annual meetingJournal of immunotherapy. 1993, Vol 13, Num 1, pp 55-75, issn 1053-8550Conference Paper

Annual Scientific Meeting of the International Society for Biological Therapy of CancerJournal of immunotherapy (1997). 2010, Vol 33, Num 8, pp 859-920, issn 1524-9557, 62 p.Conference Paper

Annual Scientific Meeting of the International Society for Biological Therapy of CancerJournal of immunotherapy (1997). 2007, Vol 30, Num 8, pp 855-904, issn 1524-9557, 49 p.Conference Paper

Recombinant vaccinia interleukin-2-infected tumor cell vaccines in immunotherapy of murine colon adenocarcinomaBASH, J. A.Journal of immunotherapy. 1993, Vol 14, Num 4, pp 269-272, issn 1053-8550Conference Paper

Immunoadsorption in multifocal motor neuropathyFINSTERER, J; DERFLER, K.Journal of immunotherapy (1997). 1999, Vol 22, Num 5, pp 441-442, issn 1524-9557Conference Paper

Liposome-encapsulated MTP-PE : a novel biologic agent of cancer therapyASANO, T; KLEINERMAN, E. S.Journal of immunotherapy. 1993, Vol 14, Num 4, pp 286-292, issn 1053-8550Conference Paper

CTLA4 blockade maximizes antitumor T-cell activation by dendritic cells presenting idiotype protein or opsonized anti-CD20 antibody-coated lymphoma cellsHSU, Frank J; KOMAROVSKAYA, Marina.Journal of immunotherapy (1997). 2002, Vol 25, Num 6, pp 455-468, issn 1524-9557, 14 p.Conference Paper

Immunohistologic responses within dermal metastatic melanoma lesions of patients treated with a synthetic peptide vaccineFRITSCH, Michael; ROSENBERG, Steven A; DURAY, Paul H et al.Journal of immunotherapy (1997). 2000, Vol 23, Num 5, pp 557-569, issn 1524-9557Conference Paper

Expansion of tumor-infiltrating lymphocytes from human tumors using the T-cell growth factors interleukin-2 and interleukin-4KAWAKAMI, Y; HAAS, G. P; LOTZE, M. T et al.Journal of immunotherapy. 1993, Vol 14, Num 4, pp 336-347, issn 1053-8550Conference Paper

In vivo antitumor efficacy of tumor-draining lymph node cells activated with nonspecific T-cell reagentsSUYU SHU; SUSSMAN, J. J; CHANG, A. E et al.Journal of immunotherapy. 1993, Vol 14, Num 4, pp 279-285, issn 1053-8550Conference Paper

Cytokines and immune response in the tumor microenvironmentMOCELLIN, Simone; ENA WANG; MARINCOLA, Francesco Maria et al.Journal of immunotherapy (1997). 2001, Vol 24, Num 5, pp 392-407, issn 1524-9557Conference Paper

Cytokines and growth factors in cancer: from basic research to clinical application. International symposiumAnnals of hematology. Supplement. 1993, Vol 67, Num 2, issn 0945-8077, 39 p.Conference Proceedings

Induction of antitumor immunity by intracerebrally implanted rat C6 glioma cells genetically engineered to secrete cytokinesTSENG, S.-H; HWANG, L.-H; LIN, S.-M et al.Journal of immunotherapy with emphasis on tumor immunology. 1997, Vol 20, Num 5, pp 334-342, issn 1067-5582Conference Paper

In vivo binding and antitumor activity of Ch14.18KENDRA, K; MALKOVSKA, V; ALLEN, M et al.Journal of immunotherapy (1997). 1999, Vol 22, Num 5, pp 423-430, issn 1524-9557Conference Paper

Hyperthermia enhances the cytotoxicity of national institutes of health 3T3 cell transfected with a noncleavable transmembrane pro-tumor necrosis factor deletion mutantTOMASOVIC, S. P; KHODADADIAN, M; MIEN-CHIE HUNG et al.Journal of immunotherapy. 1994, Vol 16, Num 3, pp 181-187, issn 1053-8550Conference Paper

Effects of tumor necrosis factor-α on the in vitro maturation of tumor-reactive effector T cellsTANIGAWA, Keishi; CRAIG, Ronald A; STOOLMAN, Lloyd M et al.Journal of immunotherapy (1997). 2000, Vol 23, Num 5, pp 528-535, issn 1524-9557Conference Paper